Devyser Diagnostics AB (DVYSR) — Cash Flow Reinvestment Rate
Devyser Diagnostics AB (DVYSR) has a Cash Flow Reinvestment Rate of 0.02x as of March 2026, reinvesting Skr300.00K (capex Skr300.00K ) from operating cash flow of Skr12.10 Million. Check Devyser Diagnostics AB (DVYSR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Devyser Diagnostics AB Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Devyser Diagnostics AB across 4 annual periods. Explore DVYSR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Devyser Diagnostics AB (2018–2025)
Year-by-year capital reinvestment analysis for Devyser Diagnostics AB. For live market cap and broader valuation context, see Devyser Diagnostics AB stock valuation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | Skr2.00 Million | Skr8.20 Million | Skr1.50 Million | ▼ -98.1% |
| 2020 | 12.96x | Skr8.13 Million | Skr627.00K | Skr3.41 Million | ▲ +1936.5% |
| 2019 | 0.64x | Skr9.31 Million | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr5.06 Million | Skr6.02 Million | Skr5.06 Million | — |